Neuroleptic malignant syndrome: A review of diagnosis and treatment

Background Neuroleptic Malignant Syndrome is a life-threatening neuropsychiatric emergency because of the use of Neuroleptic drugs characterized by specifically clinical syndrome, like changes in mental status, stiffness, fever, and dysautonomia. The current problem in managing of the Neuroleptic Ma...

Full description

Saved in:
Bibliographic Details
Main Authors: Putra Patria Yudha, -, Yunias Setiawati, -
Format: Article PeerReviewed
Language:English
English
English
English
Published: The Indian Society of Toxicology 2020
Subjects:
Online Access:https://repository.unair.ac.id/116370/1/C8-Artikel.pdf
https://repository.unair.ac.id/116370/2/C8-Bukti%20Korespondensi.pdf
https://repository.unair.ac.id/116370/3/C8-Peer%20Review.pdf
https://repository.unair.ac.id/116370/4/C8-Similarity.pdf
https://repository.unair.ac.id/116370/
https://indianjournals.com/ijor.aspx?target=ijor:jist&volume=16&issue=2&article=007
http://dx.doi.org/10.31736/2020v16i2/32-38
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Universitas Airlangga
Language: English
English
English
English
Description
Summary:Background Neuroleptic Malignant Syndrome is a life-threatening neuropsychiatric emergency because of the use of Neuroleptic drugs characterized by specifically clinical syndrome, like changes in mental status, stiffness, fever, and dysautonomia. The current problem in managing of the Neuroleptic Malignant Syndrome is still not yet optimized causing the death rate is quite high with an incidence rate of the Neuroleptic Malignant Syndrome is ranging from 0.02 to 3 percent among patients taking anti psychotic agents occur throughout the world. Methods From published articles conducted by the experts that concerning in Neuroleptic malignant syndromes and its management have been considered and reviewed. Comments It is important for medical workers to understand steps in managing and treating Neuroleptic Malignant Syndrome from the initial management such as the immediate termination of Neuroleptic Malignant Syndrome drug agents, giving supportve management, early detection of clinical symptoms, Prevention of risk factors untl understanding the medical conditons associated with Neuroleptic Malignant Syndrome specifically.